Evidence map›Paper›PMID 41709048›Full record

ArticleParasitology research2026

Enhanced YOLO-based framework and benchmarking for automated Plasmodium vivax detection.

Vivek Morris Prathap, Sonam Yadav

Abstract read
In one paragraph

Article in Parasitology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vivek Morris PrathapFaculty of Biotechnology, Shri Ramswaroop Memorial University, Lucknow-Deva Road, Barabanki, Uttar Pradesh, 225003, India.
Sonam YadavFaculty of Biotechnology, Shri Ramswaroop Memorial University, Lucknow-Deva Road, Barabanki, Uttar Pradesh, 225003, India. sonamyadav.ipc@gmail.com.ORCID http://orcid.org/0000-0002-6440-4675

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite remarkable progress in global health and increased life expectancy in the 21st century, malaria remains a major parasitic disease-causing significant morbidity and mortality, particularly in sub-Saharan Africa and Southeast Asia. Traditional diagnostic methods such as rapid diagnostic tests (RDTs) and microscopy, though widely used, suffer from limitations including biomarker mutations, reduced sensitivity at low parasite counts, and operator dependency. These challenges underscore the need for intelligent, automated diagnostic solutions. Artificial intelligence (AI)-driven computer vision methods, especially deep learning (DL)-enabled object detection architectures, offer promising alternatives for automated parasite identification. This study aims to perform a comparative evaluation of YOLO variants (v3, cascade v3, scaled v4, v5, and v8) to determine the most suitable architecture for precise and efficient detection of malaria. The models were assessed with following parameters such as, precision, accuracy, F1-score, recall and mean Average Precision (mAP). This study proposes a novel DL framework that combines YOLOv3 with a modified MobileNetV2 backbone, augmented by a Transformed Convolutional Layer (TCL)exhibits multi-scale texture sensitivity and efficient feature extraction, making it particularly effective for analyzing dense thick smear images of Plasmodium vivax (P. vivax).These findings provide guidance for deploying AI-based malaria diagnostic tools across varied clinical and field settings.This approach aims to contribute toward developing a robust, scalable, and interpretable diagnostic framework for early malaria detection and improved disease management.

Indexed as

Image Processing, Computer-AssistedMalaria, VivaxPlasmodium vivaxArtificial IntelligenceDeep LearningDetection AlgorithmsHumansMicroscopyRapid Diagnostic TestsSensitivity and SpecificityDeep learningMalariaMobileNetv2Plasmodium vivaxYOLO model

Identifiers

PMID41709048
PMCPMC12920716

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.